Severe cellulitis caused by Achromobacter xylosoxidans after allogeneic hematopoietic stem cell transplantation. Issue 5 (May 2021)

• Record Type: Journal Article
• Authors: Oyama, Yu; Yasunaga, Megumi; Honda, Akira; Maki, Hiroaki; Masamoto, Yosuke; Kobayashi, Tatsuya; Wakabayashi, Yoshitaka; Okugawa, Shu; Moriya, Kyoji; Kurokawa, Mineo
• Is Part Of: Journal of infection and chemotherapy. Volume 27:Issue 5(2021)
• Page Start: 770
• Page End: 772
• Publication Date: 2021-05
• Subjects: Achromobacter xylosoxidans -- Cellulitis -- Hematopoietic stem cell transplantation -- Chronic graft versus host disease; Chemotherapy -- Periodicals; Infection -- Periodicals; Communicable diseases -- Chemotherapy -- Periodicals; 615.5805
• DOI: 10.1016/j.jiac.2020.12.025
• Languages: English
• ISSNs: 1341-321X

Abstract

Abstract: Achromobacter xylosoxidans ( A. xylosoxidans ) is an aerobic gram-negative bacillus and often isolated from aquatic environments. It is supposed to cause infections in patients with malignancy or immunodeficiency. It causes various healthcare-associated infections, but cellulitis is rare. Herein, we report the first case of sever cellulitis by A. xylosoxidans after allogeneic hematopoietic stem cell transplantation (HSCT). A 49-year-old man underwent allogeneic HSCT from 8/8 HLA-matched unrelated donor with myeloablative conditioning for relapsed acute myeloid leukemia. He developed skin chronic graft versus host disease 11 months after HSCT. During the prolonged treatment with prednisolone and cyclosporine, he developed cellulitis on his left leg and admitted to our hospital. Blood and exudate culture revealed A. xylosoxidans . Although empirical therapy with cefepime was ineffective, his symptoms were dramatically improved after administration of meropenem. To our knowledge, this is the first case of A. xylosoxidans cellulitis after allogeneic HSCT. A. xylosoxidans should be considered as a possible cause of cellulitis in post-allogeneic HSCT patients on prolonged immunosuppressive therapy.